Table of Content

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on United Kingdom Precision Medicine Market
4. Executive Summary
5. Voice of Customer
6. United Kingdom Precision Medicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products and Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services)
6.2.2. By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, Next Generation Sequencing (NGS), Others)
6.2.3. By Application (Oncology, Immunology, Cardiology, Neurology, Respiratory, Others)
6.2.4. By End-User (Pharmaceutical and Biotechnology Companies, Healthcare IT, Diagnostic Companies, Clinical Research Organization, Research Institutes)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. United Kingdom Precision Medicine Platforms Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Application
7.2.3. By End User
8. United Kingdom Precision Medicine Tools Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Application
8.2.3. By End User
9. United Kingdom Precision Medicine Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Application
9.2.3. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. United Kingdom Economic Profile
14. Competitive Landscape
14.1. Thermo Fischer Scientific United Kingdom
14.2. Qiagen Manchester Limited
14.3. Illumina Cambridge Limited
14.4. Quest Diagnostic Limited
14.5. Agilent Technologies UK Limited
14.6. GlaxoSmithKline Plc.
14.7. Roche Diagnostics Limited
15. Strategic Recommendations